Cerebral effect of paracetamol measured by f-MRI

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-004908-20-BE

Enrollment

Registered

2013-11-25

Start date

2013-12-23

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Trade Name: Paracetamol Pharmaceutical Form: Tablet INN or Proposed INN: paracetamol Current Sponsor code: BE392296 Other descriptive name: PARACETAMOL Concentration unit: mg milligram(s) Concentratio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers aged 18 to 65, not pregnant. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Allergy to paracetamol Medical devices not allowed in a f-MRI Claustrophobia

Design outcomes

Primary

Measure	Time frame
Main Objective: Evaluation of the cerebral activity of paracetamol, assessed by f-MRI ;Secondary Objective: N/A;Primary end point(s): N/A;Timepoint(s) of evaluation of this end point: N/A	—

Secondary

Measure	Time frame
Secondary end point(s): N/A;Timepoint(s) of evaluation of this end point: N/A	—

Countries

Belgium

Contacts

Public ContactDatanurse

UZ Brussel

veerle.vanmossevelde@uzbrussel.be3224763134

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026